NOVO-RYTHRO ETHYLSUCCINATE PWS DIN 00605867
Status: Cancelled Post Market
Holder: NOVOPHARM LIMITED
Health Canada record
| Active ingredient(s) | ERYTHROMYCIN (ERYTHROMYCIN ETHYLSUCCINATE) 100 MG |
|---|---|
| Dosage form | Powder For Solution |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | J01FA01 ERYTHROMYCIN |
| Original market date | 31-Dec-1984 |
| Current status date | 10-Aug-2005 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing ERYTHROMYCIN (ERYTHROMYCIN ETHYLSUCCINATE)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00583782 | EES 600 TABLETS 600MG | AMDIPHARM LIMITED | Tablet | ERYTHROMYCIN (ERYTHROMYCIN ETHYLSUCCINATE) 600 MG | Cancelled Post Market |
| 00000299 | EES-200 | AMDIPHARM LIMITED | Powder For Suspension | ERYTHROMYCIN (ERYTHROMYCIN ETHYLSUCCINATE) 40 MG | Cancelled Post Market |
| 00000604 | EES-200 CHEWABLE TBS (ERYPED) | ABBOTT LABORATORIES, LIMITED | Tablet | ERYTHROMYCIN (ERYTHROMYCIN ETHYLSUCCINATE) 200 MG | Cancelled Post Market |
| 00453617 | EES-400 | AMDIPHARM LIMITED | Powder For Suspension | ERYTHROMYCIN (ERYTHROMYCIN ETHYLSUCCINATE) 400 MG | Cancelled Post Market |
| 00637416 | ERYTHRO-ES | AA PHARMA INC | Tablet | ERYTHROMYCIN (ERYTHROMYCIN ETHYLSUCCINATE) 600 MG | Cancelled Post Market |
| 00704377 | ERYTHRO-ES TAB 600MG USP | PRO DOC LIMITEE | Tablet | ERYTHROMYCIN (ERYTHROMYCIN ETHYLSUCCINATE) 600 MG | Cancelled Post Market |
| 00652318 | NOVO-RYTHRO ETHYLSUCCINATE PWR 400MG/5ML | NOVOPHARM LIMITED | Powder | ERYTHROMYCIN (ERYTHROMYCIN ETHYLSUCCINATE) 400 MG | Cancelled Post Market |
| 00605859 | NOVO-RYTHRO ETHYLSUCCINATE PWS | NOVOPHARM LIMITED | Powder For Solution | ERYTHROMYCIN (ERYTHROMYCIN ETHYLSUCCINATE) 200 MG | Cancelled Post Market |
| 00583405 | PEDIAZOLE | AMDIPHARM LIMITED | Powder For Suspension | ERYTHROMYCIN (ERYTHROMYCIN ETHYLSUCCINATE) 200 MG; SULFISOXAZOLE (SULFISOXAZOLE ACETYL) 600 MG | Cancelled Post Market |